Nutriband Inc. (NASDAQ: NTRB) FAQ: Innovation, Market Potential, and Shareholder Value
Summary
What is Nutriband Inc. (NASDAQ: NTRB) known for?
Nutriband Inc. is known for its AVERSA abuse-deterrent patch technology, designed to prevent the oral misuse of transdermal patches, particularly fentanyl, and is listed on the NASDAQ under the ticker NTRB.
How has Nutriband’s stock performed since its IPO?
Since listing on the Nasdaq in 2021, Nutriband’s stock has traded above its IPO price and hit an all-time high of $11.78 in January of this year.
What is the market potential for Nutriband’s AVERSA technology?
Nutriband’s AVERSA abuse-deterrent patch technology could command a market potential as high as $800 million annually and is FDA-bound.
Who is Serguei Melnik and what is his role at Nutriband?
Serguei Melnik is the Founder and President of Nutriband, known for his no-nonsense approach to biotech entrepreneurship and focus on long-term value.
Where can I find the latest news and updates about Nutriband?
The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB.
What makes Nutriband’s approach to biotech entrepreneurship unique?
Nutriband’s approach, as highlighted by Serguei Melnik, stands in stark contrast to the conventional biotech playbook with its grounded tone and unwavering focus on long-term value.
How can I receive alerts from BioMedWire about biotech news?
To receive SMS alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only). More information is available at https://www.BioMedWire.com.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 110300